Immunological therapy of sepsis: experimental therapies.
Arndt
P
P
Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado Health Sciences Center, 4200 E. Ninth Avenue, Denver, CO 80262, USA.
Abraham
E
E
D000925:Anticoagulants / Q000627:therapeutic use; D004731:Endotoxins / Q000037:antagonists & inhibitors; D006801:Humans; D007167:Immunotherapy / Q000379:methods*; D009569:Nitric Oxide / Q000037:antagonists & inhibitors; D010741:Phospholipases A / Q000037:antagonists & inhibitors; D017472:Receptors, Interleukin-1 / Q000037:antagonists & inhibitors; D018805:Sepsis / Q000276:immunology / Q000503:physiopathology / Q000628:therapy*; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000925:Anticoagulants; D004731:Endotoxins; D017472:Receptors, Interleukin-1; D014409:Tumor Necrosis Factor-alpha; D009569:Nitric Oxide; D010741:Phospholipases A